Literature DB >> 21382632

Mechanism of HSV infection through soluble adapter-mediated virus bridging to the EGF receptor.

Kenji Nakano1, Masatoshi Kobayashi, Kei-ichiro Nakamura, Takeshi Nakanishi, Ryutaro Asano, Izumi Kumagai, Hideaki Tahara, Michihiko Kuwano, Justus B Cohen, Joseph C Glorioso.   

Abstract

Herpes simplex virus entry into cells requires the binding of envelope glycoprotein D (gD) to an entry receptor. Depending on the cell, entry occurs by different mechanisms, including fusion at the cell surface or endocytosis. Here we examined the entry mechanism through a non-HSV receptor mediated by a soluble bi-specific adapter protein composed of recognition elements for gD and the EGF receptor (EGFR). Virus entered into endosomes using either EGF or an EGFR-specific single chain antibody (scFv) for receptor recognition. Infection was less efficient with the EGF adapter which could be attributed to its weaker binding to a viral gD. Infection mediated by the scFv adapter was pH sensitive, indicating that gD-EGFR bridging alone was insufficient for capsid release from endosomes. We also show that the scFv adapter enhanced infection of EGFR-expressing tumor tissue in vivo. Our results indicate that adapters may retarget HSV infection without drastically changing the entry mechanism.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21382632      PMCID: PMC3085989          DOI: 10.1016/j.virol.2011.02.014

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  29 in total

Review 1.  Three classes of cell surface receptors for alphaherpesvirus entry.

Authors:  P G Spear; R J Eisenberg; G H Cohen
Journal:  Virology       Date:  2000-09-15       Impact factor: 3.616

2.  Bispecific adapter-mediated retargeting of a receptor-restricted HSV-1 vector to CEA-bearing tumor cells.

Authors:  Hyunjung Baek; Hiroaki Uchida; Kyungok Jun; Jae-Hong Kim; Masahide Kuroki; Justus B Cohen; Joseph C Glorioso; Heechung Kwon
Journal:  Mol Ther       Date:  2010-10-05       Impact factor: 11.454

3.  Cellular and viral requirements for rapid endocytic entry of herpes simplex virus.

Authors:  Anthony V Nicola; Stephen E Straus
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 4.  Herpes simplex virus: receptors and ligands for cell entry.

Authors:  Patricia G Spear
Journal:  Cell Microbiol       Date:  2004-05       Impact factor: 3.715

5.  Entry of herpes simplex virus mediated by chimeric forms of nectin1 retargeted to endosomes or to lipid rafts occurs through acidic endosomes.

Authors:  Tatiana Gianni; Gabriella Campadelli-Fiume; Laura Menotti
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

6.  Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22.

Authors:  N Wu; S C Watkins; P A Schaffer; N A DeLuca
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

7.  Prolonged biologically active transgene expression driven by HSV LAP2 in brain in vivo.

Authors:  Veljko Puskovic; Darren Wolfe; James Goss; Shaohua Huang; Marina Mata; Joseph C Glorioso; David J Fink
Journal:  Mol Ther       Date:  2004-07       Impact factor: 11.454

8.  Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells.

Authors:  Anthony V Nicola; Anna M McEvoy; Stephen E Straus
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

9.  Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity.

Authors:  G N Gill; T Kawamoto; C Cochet; A Le; J D Sato; H Masui; C McLeod; J Mendelsohn
Journal:  J Biol Chem       Date:  1984-06-25       Impact factor: 5.157

10.  Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors.

Authors:  V W van Beusechem; D C J Mastenbroek; P B van den Doel; M L M Lamfers; J Grill; T Würdinger; H J Haisma; H M Pinedo; W R Gerritsen
Journal:  Gene Ther       Date:  2003-11       Impact factor: 5.250

View more
  7 in total

1.  Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus.

Authors:  Yu Okubo; Hiroaki Uchida; Aika Wakata; Takuma Suzuki; Tomoko Shibata; Hitomi Ikeda; Miki Yamaguchi; Justus B Cohen; Joseph C Glorioso; Mitsuo Tagaya; Hirofumi Hamada; Hideaki Tahara
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

Review 2.  Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress.

Authors:  Balveen Kaur; E Antonio Chiocca; Timothy P Cripe
Journal:  Curr Pharm Biotechnol       Date:  2012-07       Impact factor: 2.837

3.  Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus.

Authors:  Hiroaki Uchida; Marco Marzulli; Kenji Nakano; William F Goins; Janet Chan; Chang-Sook Hong; Lucia Mazzacurati; Ji Young Yoo; Amy Haseley; Hiroshi Nakashima; Hyunjung Baek; Heechung Kwon; Izumi Kumagai; Masahide Kuroki; Balveen Kaur; E Antonio Chiocca; Paola Grandi; Justus B Cohen; Joseph C Glorioso
Journal:  Mol Ther       Date:  2012-10-16       Impact factor: 11.454

4.  Annexin A2 and S100A10 regulate human papillomavirus type 16 entry and intracellular trafficking in human keratinocytes.

Authors:  Agnieszka Dziduszko; Michelle A Ozbun
Journal:  J Virol       Date:  2013-05-01       Impact factor: 5.103

5.  Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections.

Authors:  Zurab Surviladze; Agnieszka Dziduszko; Michelle A Ozbun
Journal:  PLoS Pathog       Date:  2012-02-09       Impact factor: 6.823

Review 6.  Role of EGF Receptor Regulatory Networks in the Host Response to Viral Infections.

Authors:  Cathleen R Carlin
Journal:  Front Cell Infect Microbiol       Date:  2022-01-10       Impact factor: 5.293

7.  GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal Survival.

Authors:  Paola Sette; Nduka Amankulor; Aofei Li; Marco Marzulli; Daniela Leronni; Mingdi Zhang; William F Goins; Balveen Kaur; Chelsea Bolyard; Timothy P Cripe; Jianhua Yu; E Antonio Chiocca; Joseph C Glorioso; Paola Grandi
Journal:  Mol Ther Oncolytics       Date:  2019-10-24       Impact factor: 7.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.